|0.8530||+0.0330||+4.02%||Vol 2.45M||1Y Perf -50.30%|
|Aug 5th, 2022 16:00 DELAYED|
|- -||0.00 0.56%|
|Target Price||4.83||Analyst Rating||Moderate Buy 1.67|
|Potential %||466.24||Finscreener Ranking||★★ 44.53|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★ 38.28|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★ 52.50|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||25.37||Earnings Rating||Strong Buy|
|Market Cap||123.34M||Earnings Date||4th Aug 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Mngmt Effectiveness||Value||Industry||S&P 500||US Markets|
ROE (5Y Avg)
ROE last 12 Months
ROA (5Y Avg)
ROA last 12 Months
ROC (5Y Avg)
ROC last 12 Months
Return on invested Capital Q
Return on invested Capital Y
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-0.19|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||1.56M|
|Avg. Monthly Volume||1.57M|
|Avg. Quarterly Volume||2.37M|
Ardelyx Inc. (NASDAQ: ARDX) stock closed at 0.853 per share at the end of the most recent trading day (a 4.02% change compared to the prior day closing price) with a volume of 2.45M shares and market capitalization of 123.34M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 88 people. Ardelyx Inc. CEO is Michael G. Raab.
The one-year performance of Ardelyx Inc. stock is -50.3%, while year-to-date (YTD) performance is -22.45%. ARDX stock has a five-year performance of -82.23%. Its 52-week range is between 0.4902 and 1.92, which gives ARDX stock a 52-week price range ratio of 25.37%
Ardelyx Inc. currently has a PE ratio of -0.50, a price-to-book (PB) ratio of 1.58, a price-to-sale (PS) ratio of 36.74, a price to cashflow ratio of 58.30, a PEG ratio of 2.32, a ROA of -93.35%, a ROC of -105.17% and a ROE of -163.10%. The company’s profit margin is -%, its EBITDA margin is -3 707.70%, and its revenue ttm is $2.67 Million , which makes it $0.02 revenue per share.
Of the last four earnings reports from Ardelyx Inc., there were 0 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.19 for the next earnings report. Ardelyx Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Ardelyx Inc. is Moderate Buy (1.67), with a target price of $4.83, which is +466.24% compared to the current price. The earnings rating for Ardelyx Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Ardelyx Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Ardelyx Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 10.35, ATR14 : 0.07, CCI20 : 243.75, Chaikin Money Flow : 0.16, MACD : 0.03, Money Flow Index : 77.05, ROC : 15.76, RSI : 59.81, STOCH (14,3) : 92.45, STOCH RSI : 1.00, UO : 60.22, Williams %R : -7.55), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Ardelyx Inc. in the last 12-months were: David P. Rosenbaum (Sold 67 640 shares of value $44 916 ), Elizabeth Grammer (Sold 63 147 shares of value $41 644 ), Forest Baskett (Sold 2 881 570 shares of value $3 642 571 ), Jeffrey Jacobs (Sold 13 661 shares of value $14 813 ), Justin A. Renz (Sold 77 914 shares of value $51 398 ), Michael G. Raab (Sold 121 157 shares of value $81 684 ), Robert Blanks (Sold 83 015 shares of value $54 816 ), Sandell D Scott (Sold 2 881 570 shares of value $3 642 571 ), Susan Rodriguez (Sold 52 018 shares of value $34 621 )
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.